|The University of Adelaide||Home | Faculties & Divisions | Search|
|Faculties & Divisions | People A to Z | Media Expertise | Phonebook||
|Public browsing [Login]|
Professor Robert Vink
To link to this page, please use the following URL:
Professor Robert Vink
Professor Vink was awarded his BSc(Hons) and PhD at Griffith University (Brisbane) and then a Sandoz Neuroscience Postdoctoral Fellowship in the Neurology Department of the University of California at San Francisco (UCSF) where he was subsequently appointed as an Assistant Research Professor. He was then awarded a Queen Elizabeth II Research Fellowship in 1988 to return to Australia to undertake research at James Cook University (JCU) in Townsville, North Queensland, where at the conclusion of his research fellowship, he was appointed to an academic lectureship position. At JCU, he was promoted to Senior Lecturer and then Associate Professor and Head of Department of Physiology and Pharmacology. Following a period of sabattical research as an Adjunct Professor in Neuroscience at Georgetown University, Washington DC, he joined the Department of Pathology at the University of Adelaide in 2001 and was subsequently appointed as the NRF Chair of Neurosurgical Research and as the Head of School of Medical Sciences. In 2014, Bob was appointed Pro Vice Chancellor (Health Sciences) at the University of South Australia and now maintains an Adjunct Professor position with the University of Adelaide.
His research has focused on the recognition of secondary injury factors following injury to the central nervous system, and the development of novel pharmacotherapies that improve functional outcome. He is particularly noted for his characterisation of the role of magnesium in traumatic brain injury, for which he was awarded a DSc (Adelaide) in 2012. More recently, he has been characterising the role of neurogenic inflammation in acute and chronic brain injury, particularly its role in brain oedema, the development of elevated intracranial pressure and in chronic traumatic encephalopathy (CTE). His patents in the area of neurogenic inflammation have been licensed to pharmaceutical industry and are currently undergoing clinical development.
In 2004, Bob was the invited Japanese Society for Neurotraumatology Visiting Professor and in 2009 was awarded the Jamieson Memorial Lecture and medal at the Australasian Neurosurgical Society annual meeting. In 2015, Bob gave the Eccles Lecture at the annual meeting of the Australasian Neuroscience Society, where he was awarded the Australasian Neuroscience Society medal, and at the annual meeting of Neurosurgical Society of Australasia, and was inducted as a Fellow of the Australian Academy of Health and Medical Sciences. He is currently an Executive Commitee member of the International Neurotrauma Society.
Copyright © 2013 The University of Adelaide
Last Modified 26/07/2013 Marketing & Communications
CRICOS Provider Number 00123M